SB 79 is a broad health care bill that revises several Missouri statutes affecting public health, Medicaid, telehealth, insurance, and reproductive health coverage. It expands expedited partner therapy for sexually transmitted infections beyond chlamydia and gonorrhea to other infections designated by the Department of Health and Senior Services or recommended in CDC guidelines, and it authorizes licensed physicians and other qualified health care professionals to prescribe and dispense treatment for partners without a prior patient relationship. The bill also updates Missouri’s telehealth law to define telemedicine more broadly, expressly include asynchronous store-and-forward services, and clarify that licensed providers may deliver telehealth within their scope of practice using HIPAA-compliant platforms.
The measure makes several changes to MO HealthNet. It adds a new prohibition on Medicaid payments for gender transition surgeries, cross-sex hormones, and puberty-blocking drugs when used for gender transition. It also revises existing Medicaid coverage and administration provisions, including rules for prior authorization, reimbursement, provider notice requirements when audit interpretations change, and coverage-related language for multiple categories of services. In addition, the bill removes the prior statutory requirement that health maintenance organizations be examined at least once every five years, allowing the director to examine them as often as necessary.
SB 79 also creates a new insurance-related coverage mandate for self-administered hormonal contraceptives. Health benefit plans issued or renewed on or after January 1, 2026, that cover these contraceptives must reimburse a provider or dispensing entity for up to a 90-day supply, or up to 180 days for generic products, and the coverage cannot have a higher deductible or copayment than comparable services. The bill further establishes a new framework for “contracts for health care benefits” offered by qualified membership organizations, including farm bureaus and similarly large membership entities, and expressly states that these arrangements are not insurance and are generally exempt from Missouri insurance laws, while still requiring certain disclosures, complaint review, and minimum benefit categories.
The bill’s impact on state law is significant because it amends multiple chapters at once, including public health, Medicaid, insurance, and health maintenance organization regulation. It expands provider authority in telehealth and expedited partner therapy, changes Medicaid benefit and reimbursement rules, creates new contraceptive coverage requirements for health plans, and sets up a separate regulatory category for membership-based health care benefit contracts. It also repeals the dense breast mammography notice statute by striking section 192.769, removing that prior patient-notice requirement from Missouri law.
The overall sentiment reflected in the voting history appears strongly favorable, with the bill passing the Senate 24-6 and the House 147-1 on the informal substitute. The broad margins suggest substantial bipartisan support, though the bill’s contents indicate likely areas of policy disagreement. The most notable points of contention are the prohibition on Medicaid coverage for gender transition-related care, the exemption of membership organization health benefit contracts from insurance regulation, and the repeal of the dense breast notification provision. Supporters likely viewed the bill as a package of health care access, telehealth, and regulatory updates, while opponents may have focused on the reproductive health, transgender care, and insurance-regulation provisions.
SB 79 repeals and reenacts provisions in several Missouri statutes, expanding expedited partner therapy authority, modernizing telehealth definitions and licensing rules, changing MO HealthNet coverage and reimbursement policies, creating a new contraceptive coverage mandate for certain health plans, and establishing a separate legal framework for membership-based health care benefit contracts that are largely exempt from insurance law. It also removes the existing dense breast mammography notice statute and modifies HMO examination authority, affecting physicians, pharmacists, telehealth providers, Medicaid participants and providers, insurers, and qualified membership organizations such as farm bureaus.
The bill appears to have been broadly supported in both chambers, as reflected by the 24-6 Senate vote and the 147-1 House vote on the informal substitute. The voting margins suggest the package was generally viewed favorably as a health care measure, likely because it combines telehealth expansion, public health updates, and insurance-related changes. At the same time, the bill includes several policy choices that are likely to have drawn criticism from some lawmakers and stakeholders, especially the Medicaid exclusion for gender transition care and the creation of a new non-insurance health benefits category.
The main points of contention are likely the bill’s prohibition on MO HealthNet payments for gender transition surgeries, cross-sex hormones, and puberty-blocking drugs; the creation of a membership-organization health care benefits model that is exempt from most insurance regulation; and the repeal of the dense breast notification requirement. Supporters would likely emphasize expanded access through telehealth, expedited partner therapy, and contraceptive coverage, while opponents may argue that the bill restricts certain medical care, weakens consumer protections for health coverage, or removes patient-notice protections. The absence of committee transcript debate in the provided record limits direct attribution of specific arguments, but these provisions are the most policy-sensitive parts of the bill.